Nuzenio

Theriva Biologics Inc

Theriva Biologics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 17:47:37 GMTTheriva Biologics Inc (TOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Thu, 06 Aug 2026 18:27:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Phase 2a Trial to Refine VCN-01 Therapy for Metastatic Pancreatic Cancer – Minichart - Minichart
Thu, 06 Aug 2026 12:11:14 GMTTheriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock Titan
Thu, 06 Aug 2026 12:00:00 GMTTheriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswire
Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock Titan
Tue, 04 Aug 2026 11:20:42 GMTTheriva Biologics (NYSE American: TOVX) holders back bigger stock plan, warrants - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Theriva Biologics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.